Prices are falling for the popular obesity treatments Wegovy and Zepbound, but steady access to the drugs remains challenging. The medications still amount to around $500 per month for those without ...

Reproductive and obesity medicine experts tell USA TODAY that they’re also noticing the trend in their offices, and it boils down to two main reasons.  Weight loss can help correct ...

As summer began and temperatures rose in June, so too did TV ad spending for Novo Nordisk’s Wegovy. | As summer began and ...